These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35474966)

  • 1. Extracting functional insights from loss-of-function screens using deep link prediction.
    Strybol PP; Larmuseau M; de Schaetzen van Brienen L; Van den Bulcke T; Marchal K
    Cell Rep Methods; 2022 Feb; 2(2):100171. PubMed ID: 35474966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.
    Krill-Burger JM; Dempster JM; Borah AA; Paolella BR; Root DE; Golub TR; Boehm JS; Hahn WC; McFarland JM; Vazquez F; Tsherniak A
    Genome Biol; 2023 Aug; 24(1):192. PubMed ID: 37612728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration.
    McFarland JM; Ho ZV; Kugener G; Dempster JM; Montgomery PG; Bryan JG; Krill-Burger JM; Green TM; Vazquez F; Boehm JS; Golub TR; Hahn WC; Root DE; Tsherniak A
    Nat Commun; 2018 Nov; 9(1):4610. PubMed ID: 30389920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inferring cancer dependencies on metabolic genes from large-scale genetic screens.
    Lagziel S; Lee WD; Shlomi T
    BMC Biol; 2019 Apr; 17(1):37. PubMed ID: 31039782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.
    Jaiswal A; Peddinti G; Akimov Y; Wennerberg K; Kuznetsov S; Tang J; Aittokallio T
    Genome Med; 2017 Jun; 9(1):51. PubMed ID: 28569207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimensionality reduction methods for extracting functional networks from large-scale CRISPR screens.
    Hassan AZ; Ward HN; Rahman M; Billmann M; Lee Y; Myers CL
    Mol Syst Biol; 2023 Nov; 19(11):e11657. PubMed ID: 37750448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimensionality reduction methods for extracting functional networks from large-scale CRISPR screens.
    Zernab Hassan A; Ward HN; Rahman M; Billmann M; Lee Y; Myers CL
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting lncRNA-disease associations using network topological similarity based on deep mining heterogeneous networks.
    Zhang H; Liang Y; Peng C; Han S; Du W; Li Y
    Math Biosci; 2019 Sep; 315():108229. PubMed ID: 31323239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for benchmarking genetic screens reveals a predominant mitochondrial bias.
    Rahman M; Billmann M; Costanzo M; Aregger M; Tong AHY; Chan K; Ward HN; Brown KR; Andrews BJ; Boone C; Moffat J; Myers CL
    Mol Syst Biol; 2021 May; 17(5):e10013. PubMed ID: 34018332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
    Shi B; Ding J; Qi J; Gu Z
    Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics.
    Hart T; Brown KR; Sircoulomb F; Rottapel R; Moffat J
    Mol Syst Biol; 2014 Jul; 10(7):733. PubMed ID: 24987113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment.
    Xue VW; Wong SCC; Cho WCS
    Expert Opin Ther Targets; 2020 Nov; 24(11):1147-1158. PubMed ID: 32893711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying synthetic lethal targets using CRISPR/Cas9 system.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network-based integrative approach to prioritize reliable hits from multiple genome-wide RNAi screens in Drosophila.
    Wang L; Tu Z; Sun F
    BMC Genomics; 2009 May; 10():220. PubMed ID: 19435510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multivariate Computational Method to Analyze High-Content RNAi Screening Data.
    Rameseder J; Krismer K; Dayma Y; Ehrenberger T; Hwang MK; Airoldi EM; Floyd SR; Yaffe MB
    J Biomol Screen; 2015 Sep; 20(8):985-97. PubMed ID: 25918037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.
    Pacini C; Duncan E; Gonçalves E; Gilbert J; Bhosle S; Horswell S; Karakoc E; Lightfoot H; Curry E; Muyas F; Bouaboula M; Pedamallu CS; Cortes-Ciriano I; Behan FM; Zalmas LP; Barthorpe A; Francies H; Rowley S; Pollard J; Beltrao P; Parts L; Iorio F; Garnett MJ
    Cancer Cell; 2024 Feb; 42(2):301-316.e9. PubMed ID: 38215750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using iterative cluster merging with improved gap statistics to perform online phenotype discovery in the context of high-throughput RNAi screens.
    Yin Z; Zhou X; Bakal C; Li F; Sun Y; Perrimon N; Wong ST
    BMC Bioinformatics; 2008 Jun; 9():264. PubMed ID: 18534020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference screening for the discovery of oncology targets.
    Quon K; Kassner PD
    Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.